CA-WETA-DIGITAL
17.12.2020 18:17:18 CET | Business Wire | Press release
Weta Digital, one of the world’s premiere visual effects facilities and parent company of Weta Animated, has announced the addition of industry leaders Tom Staggs, Jeff Huber and Ken Kamins to its Board of Directors. The appointment of Staggs, Huber and Kamins reflect the continued growth and innovation of the company, which is also opening offices in Los Angeles and San Francisco.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201217005350/en/
“Tom, Jeff and Ken are extraordinary additions to the board of Weta Digital,” said Prem Akkaraju, Global CEO of Weta Digital. “They have established best practices at the highest levels of company management, in entertainment and digital technology. Their combined business acumen and collective depth of experience perfectly positions Weta Digital for exponential growth. Opening offices in Los Angeles and San Francisco enables storytellers to tap Weta’s production pipeline and work with concept designers, animation supervisors and other key creatives, in both the US and New Zealand. Weta Digital’s expansion comes at a time when much of the film industry is experiencing extraordinary uncertainty as we grapple with the ongoing impact of Covid-19. We’re extremely fortunate that New Zealand got in front of the curve early - it’s one of the few places in the world that has managed community transmission, where you can make a film safely, without the restrictive protocols of other markets.”
Tom Staggs brings more than 26-years of experience at The Walt Disney Company, including 18 years of C-suite experience with the company. He was most recently Disney’s Chief Operating Officer, having previously served for five years as Chairman of Disney Parks and Resorts Worldwide and for nearly 12 years as Disney’s Chief Financial Officer. During his time at Disney, Staggs helped shape Disney’s strategic, financial, operational, creative and brand management strategies across every segment of the company and helped drive many of Disney’s most important initiatives including the acquisitions of Cap Cities/ABC, Pixar and Marvel. Since departing Disney in late 2016, Staggs has focused on developing several new business ventures across a variety of fields. He is a board member and advisor to a number of private companies, and also serves on the board of directors of music streaming service Spotify. Before joining Disney, Staggs was an investment banker at Morgan Stanley and Dain Bosworth.
“I have long admired Peter Jackson and Fran Walsh’s filmmaking talents and Weta Digital’s accomplishments in animation and visual effects. Weta Digital’s rare combination of creative talent and technology gives them a unique ability to succeed in high-end animation production,” said Staggs. “I look forward to working with Peter, Fran, Prem and the entire Weta Digital team on the animation business and further global expansion.”
Jeff Huber is the former Founding CEO and Vice Chairman of GRAIL and previously a Senior Vice President at Google. Having spent over 13 years at Google, Huber co-founded the company’s life sciences efforts in Google X and led development and scaling for Google Maps, Google Apps and Google Ads. During his tenure as an executive at Google, Jeff oversaw 50x growth in revenues (from $1 billion to >$50 billion) and organization (1,000 to >50,000 employees), and managed a $5 billion P&L and large distributed teams (5,000+ direct-line employees). Prior to Google, Huber served as Vice President of Architecture and Systems Development at eBay and Senior Vice President of Engineering at Excite@Home, where he led consumer product and infrastructure development.
"Weta Digital is known around the world for its astounding visual effects and inventive storytelling. This amazing artistry is driven by groundbreaking technology and non-stop innovation,” said Huber. “The research and development teams at Weta Digital have consistently produced magic and raised the bar as to what is possible. I look forward to the adventures ahead with Peter, Fran, Prem and the entire Weta Digital Team, growing the company in scale and technology excellence to create the next generation of culture-defining stories and experiences."
Ken Kamins is the Founder and CEO of Key Creatives, a management-production company. He has represented Peter Jackson and Fran Walsh since 1992, and his Executive Producer credits include The Hobbit Trilogy , District 9 , and The Adventures of Tintin: The Secret of the Unicorn. Prior to his current position, he served as Executive Vice President of the talent agency, International Creative Management; and before that, as Executive Vice President of RCA/Columbia Pictures Home Entertainment.
“I’ve had a front row seat for the entire growth curve of Weta Digital, from its beginnings in 1993 when the company consisted of just one computer and one artist creating the digital effects in “Heavenly Creatures”, through to this moment,” said Kamins. “Weta Digital was designed by Peter and Fran to be a creative haven for filmmakers - a place where they could let their imaginations run wild. No idea was too crazy or too difficult to try. In collaboration with the many great artists Weta has had the privilege to work with, Joe Letteri, David Conley and their teams have consistently pushed the boundaries of imaginative storytelling.”
Staggs, Huber and Kamins join Weta Digital board members Peter Jackson, Fran Walsh, Sean Parker, Joe Letteri and CEO Prem Akkaraju.
ABOUT WETA DIGITAL:
Weta Digital is the standard-bearer for creativity and innovation in visual effects and animation, attracting talent, partners, and clients that seek to push what is possible in pursuit of their artistic vision. Weta’s proprietary pipeline continues to evolve and provide artists with the tools they need to create their best work. Based in Wellington, New Zealand, Weta Digital is the largest single-site VFX studio in the world drawing artists from over 40 countries. They are some of the most creative and ambitious artists, engineers, and executives in entertainment and their work has earned six visual effects Academy Awards, ten Academy Sci-Tech Awards and six visual effects BAFTA Awards in addition to the 34 Visual Effects Society Awards awarded to them by their peers. Ground-breaking, performance-driven animated characters from Gollum to Caesar, and worlds from Middle-earth to Pandora, are regarded as some of the best visual effects ever to appear on screen.
For more information:
Corporate: www.wetastudios.com
Weta Digital: www.wetafx.co.nz
Follow: @weta_digital
View source version on businesswire.com: https://www.businesswire.com/news/home/20201217005350/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
